"10.1371_journal.pone.0151575","plos one","2016-03-24T00:00:00Z","Thierry Van Effelterre; Gaël Dos Santos; Vivek Shinde","Global Epidemiology, GSK Vaccines, Wavre, Belgium; Business & Decision Life Sciences (on behalf of GSK Vaccines), Brussels, Belgium; GSK Vaccines, King of Prussia, PA, United States of America","Conceived and designed the experiments: VS TVE. Performed the experiments: TVE. Analyzed the data: TVE VS. Contributed reagents/materials/analysis tools: TVE VS GDS. Wrote the paper: TVE GDS VS. Developed the model: TVE VS. Provided epidemiology and vaccine-related expertise: VS GDS. The Principal Investigators participating in the study: VS TVE. Contributed to the subsequent revisions and approved the final version: TVE GDS VS.","Thierry Van Effelterre is an employee of the GSK group of companies. At the time this study was carried out, Vivek Shinde was an employee of the GSK group of companies. Thierry Van Effelterre and Vivek Shinde own shares in the GSK group of companies. Gaël Dos Santos reports that he is working for GSK Vaccines, but is employed by B&D Life Sciences. This does not alter the authors’ adherence to PLOS ONE policies on sharing data and materials.","2016","03","Thierry Van Effelterre","TVE",3,TRUE,2,1,2,3,TRUE,TRUE,FALSE,0,NA,FALSE
